<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860912</url>
  </required_header>
  <id_info>
    <org_study_id>IRB# 85852010</org_study_id>
    <nct_id>NCT00860912</nct_id>
  </id_info>
  <brief_title>Veritas Collagen Matrix Cystocele Repair Study - Postmarketing</brief_title>
  <official_title>Veritas Collagen Matrix Cystocele Repair Study - Postmarketing Protocol #CP1004</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Veritas Collagen Matrix in treating female
      patients with documented occurence of Pelvic Organ Prolapse as evidenced by a cystocele.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgery for cystocele repair to be performed. Native tissue repair to be randomized versus
      reinforcement with Collagen matrix
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2001</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>collagen graft reinforcement</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the ability of the VCM to treat pelvic organ prolapse as demonstrated by improvement of cystocele as measured by a comparison of POP-Q scores pre and post surgery</measure>
    <time_frame>2 years</time_frame>
    <description>prolapse degree on pelvic exam</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate patient satisfaction as measured by a comparison of Quality of Life questions at baseline and post surgery</measure>
    <time_frame>2 years</time_frame>
    <description>subjective satisfaction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Intervention: Collagen matrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cystocele repair: Veritas reinforcing material implanted for reinforcement of cystocele repair with collagen matrix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native tissue repair</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention: Cystocele repair performed: No reinforcing material used and routine performance of a cystocele repair using native tissues.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collagen Matrix</intervention_name>
    <description>surgical/reinforcing material</description>
    <arm_group_label>Intervention: Collagen matrix</arm_group_label>
    <arm_group_label>Native tissue repair</arm_group_label>
    <other_name>Veritas collagen matrix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is equal or greater than 18 years old

          -  Female

          -  Meets follow-up evaluation time frame

          -  Understands the nature of the procedure and has provided written informed consent

          -  Is scheduled to undergo vaginal pelvic reconstructive surgery

          -  Has &gt; 2nd degree midline cystocele

        Exclusion Criteria:

          -  Presence of severe mucosal ulceration

          -  Previous pelvic organ prolapse surgery using an implant that will affect the use of
             the VCM or affect the outcome of the study

          -  Allergy to bovine material

          -  Severe mucosal atrophy

          -  Shortened vaginal length as determined by Investigator

          -  Pregnant or intends to become pregnant during study

          -  Has a UTI

          -  Has vault prolapse &lt; 2nd degree cystocele
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo W Davila, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2009</study_first_submitted>
  <study_first_submitted_qc>March 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2009</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Veritas</keyword>
  <keyword>Cystocele</keyword>
  <keyword>Prolapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
    <mesh_term>Cystocele</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

